Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue
Recruiting
N/A
Interventional Study
Endometrial Neoplasms
Endometrial Cancer Stage I
Sentinel Lymph Node
Metastasis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Female
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 100 (estimated)
- Sponsor
- Dokuz Eylul University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This clinical trial evaluates lymph node mapping in newly diagnosed endometrial cancer patients undergoing surgery. The standard technique uses a 2-point methylene blue cervical injection. The study aims to determine if increasing injection points improves mapping success.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Individuals diagnosed with stage I endometrial cancer based on CT and PET-CT imaging.
* Individuals with a pathologically confirmed diagnosis of stage I endometrial cancer.
Exclusion Criteria:
Medical Conditions
* Individuals diagnosed with dementia.
* Individuals with alle…
Contacts